New RNA vaccine strategy aims to build broader immunity against mutating viruses

New research by Malaghan's Connor Laboratory, published in PNAS, shows how directing the immune system toward conserved areas of the COVID virus and its many variants using RNA technology could be a significant step toward designing broad-spectrum vaccines.